-
平臺(tái)編號(hào)：bio-69645
-
國際編號(hào)：PCS-200-012
-
細(xì)胞信息： Homo sapiens (human)
-
規(guī)格：frozen
-
用途：ATCC原裝細(xì)胞
-
服務(wù)費(fèi)用：
加載中…… - 訂購
-
注意事項(xiàng)：僅用于科學(xué)研究或者工業(yè)應(yīng)用等非醫(yī)療目的不可用于人類或動(dòng)物的臨床診斷或治療，非藥用，非食用（產(chǎn)品信息以出庫為準(zhǔn)）
Homo sapiens (human)
生長狀態(tài)：貼壁生長
ATCC Number：PCS-200-012
運(yùn)輸方式：凍存運(yùn)輸
細(xì)胞形態(tài)：其他
是否是腫瘤細(xì)胞：0
物種來源：人
數(shù)量：大量
年限：Neonatal
規(guī)格：0.1ml Name: Primary Epidermal Melanoyctes; Normal, Human, Neonatal
Biosafety Level:1
Shipped: frozen
Organism: Homo sapiens (human)
Source: Foreskin, lightly pigmented
Growth Properties: Adherent
Age: Neonatal
Morphology: Stellar, multipolar or dendritic apperance; needle-like
Volume per Vial: 1 ml
Gender: Male
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Related Products:Dermal Cell Basal Medium (ATCC PCS-200-030 )
Melanocyte Growth Kit (ATCC PCS-200-041 )
Dulbecco's Phosphate Buffered Saline (D-PBS) (ATCC 30-2200 )
Trypsin-EDTA for Primary Cells (ATCC PCS-999-003 )
Trypsin Neutralizing Solution (ATCC PCS-999-004 )
Gentamicin-Amphotericin B Solution (ATCC PCS-999-025 )
Penicillin-Streptomycin-Amphotericin B Solution (ATCC PCS-999-002 )
Phenol Red (ATCC PCS-999-001 )
Recomended Culture Conditions:See Product Information Sheet Comments:ATCC ? Normal Human Primary Epidermal Melanocytes from Neonatal Foreskin, when grown in Dermal Cell Basal Media supplemented with Melanocyte Growth Kit components, provide an ideal cell system to propagate melanocytes in low serum (less than 1.0% FBS) conditions in the absence of cholera toxin and phorbol 12-myristate 13-acetate (PMA). The cells are cryopreserved in the second passage to ensure the highest viability and plating efficiency.
Applications:Melanoma, response to UV radiation, psoriasis and other skin diseases, skin trauma (e.g., wound repair, scars, burns), cosmetic research (e.g., skin lightening compounds, skin protecting compounds)
Viability:≥ 50%
Population Doubling Capacity:≥ 15 in complete growth medium
Sterility Tests: Bacteria and Yeast: Negative
Mycoplasma: Negative
Hepatitis B Testing: Negative
Hepatitis C Testing: Negative
HIV-1 Testing: Negative
Testing: Hepatitis B: Negative
Hepatitis C: Negative
HIV: Negative
ATCC Number：PCS-200-012
運(yùn)輸方式：凍存運(yùn)輸
細(xì)胞形態(tài)：其他
是否是腫瘤細(xì)胞：0
物種來源：人
數(shù)量：大量
年限：Neonatal
規(guī)格：0.1ml Name: Primary Epidermal Melanoyctes; Normal, Human, Neonatal
Biosafety Level:1
Shipped: frozen
Organism: Homo sapiens (human)
Source: Foreskin, lightly pigmented
Growth Properties: Adherent
Age: Neonatal
Morphology: Stellar, multipolar or dendritic apperance; needle-like
Volume per Vial: 1 ml
Gender: Male
Permits/Forms:In addition to the MTA mentioned above, other ATCC and/or regulatory permits may be required for the transfer of this ATCC material. Anyone purchasing ATCC material is ultimately responsible for obtaining the permits. Please click here for information regarding the specific requirements for shipment to your location.
Related Products:Dermal Cell Basal Medium (ATCC PCS-200-030 )
Melanocyte Growth Kit (ATCC PCS-200-041 )
Dulbecco's Phosphate Buffered Saline (D-PBS) (ATCC 30-2200 )
Trypsin-EDTA for Primary Cells (ATCC PCS-999-003 )
Trypsin Neutralizing Solution (ATCC PCS-999-004 )
Gentamicin-Amphotericin B Solution (ATCC PCS-999-025 )
Penicillin-Streptomycin-Amphotericin B Solution (ATCC PCS-999-002 )
Phenol Red (ATCC PCS-999-001 )
Recomended Culture Conditions:See Product Information Sheet Comments:ATCC ? Normal Human Primary Epidermal Melanocytes from Neonatal Foreskin, when grown in Dermal Cell Basal Media supplemented with Melanocyte Growth Kit components, provide an ideal cell system to propagate melanocytes in low serum (less than 1.0% FBS) conditions in the absence of cholera toxin and phorbol 12-myristate 13-acetate (PMA). The cells are cryopreserved in the second passage to ensure the highest viability and plating efficiency.
Applications:Melanoma, response to UV radiation, psoriasis and other skin diseases, skin trauma (e.g., wound repair, scars, burns), cosmetic research (e.g., skin lightening compounds, skin protecting compounds)
Viability:≥ 50%
Population Doubling Capacity:≥ 15 in complete growth medium
Sterility Tests: Bacteria and Yeast: Negative
Mycoplasma: Negative
Hepatitis B Testing: Negative
Hepatitis C Testing: Negative
HIV-1 Testing: Negative
Testing: Hepatitis B: Negative
Hepatitis C: Negative
HIV: Negative
